Subcutaneous foslevodopa/foscarbidopa in patients with advanced Parkinson's Disease: results from a randomized, double-blind, double-dummy phase 3 trialM. Soileau, M. Spindler, J. Aldred, K. Budur, N. Fisseha,V. Fung, A. Jeong,T. Kimber, K. Klos,I. Litvan,D. O'Neill, W. Robieson,D. Standaert, S. Talapala,E. Okeanis Vaou, H. Zheng, M. Facheris,R. HauserMOVEMENT DISORDERS（2022）引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
